Ocular Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00004206
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 171
Buy Now

Ocular Drug Delivery Market Scope, Growth, Size and Share by 2028

Buy Now

Ocular Drug Delivery Market Report Ocular Drug Delivery Market Size and Share Ocular Drug Delivery Market Scope and Analysis

Ocular Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2021 US$ 16.4 Billion
Market Size by 2028 US$ 27.02 Billion
Global CAGR (2021 - 2028) 7.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
By Formulation Type
  • Liposomes and Nanoparticles
  • Solution
  • Emulsion
  • Suspension
  • Ointment
By Disease Type
  • Glaucoma
  • Diabetic Retinopathy
  • Dry Eye Syndrome
  • Macular Degeneration
  • Cataract
  • Diabetic Macular Edema
By End User
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc
  • Bausch Health Companies Inc
  • Taiwan Liposome Company Ltd
  • Ocular Therapeutix Inc
  • GRAYBUG VISION INC
  • Alimera Sciences Inc
  • Envisia Therapeutics
  • Novartis AG
  • EYEGATE PHARMACEUTICALS INC

    • Company Profiles

    • AbbVie Inc.                                         
    • Bausch Health Companies Inc.                
    • Taiwan Liposome Company, Ltd.             
    • Ocular Therapeutix, Inc.                        
    • GRAYBUG VISION, INC.                         
    • Alimera Sciences, Inc.                          
    • Envisia Therapeutics                             
    • Novartis AG                                        
    • EYEGATE PHARMACEUTICALS, INC           
    • Clearside Biomedical, Inc.